Ratan Capital Management LP Invests $1.07 Million in Danaher Corporation $DHR

Ratan Capital Management LP bought a new stake in Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 5,600 shares of the conglomerate’s stock, valued at approximately $1,067,000.

A number of other large investors have also recently bought and sold shares of the stock. Livforsakringsbolaget Skandia Omsesidigt purchased a new position in Danaher during the second quarter worth $662,000. Rakuten Investment Management Inc. purchased a new stake in shares of Danaher in the second quarter valued at $19,998,000. Glenview Trust Co purchased a new stake in shares of Danaher in the second quarter valued at $2,031,000. North Star Asset Management Inc. acquired a new stake in shares of Danaher during the second quarter valued at $23,424,000. Finally, Empowered Funds LLC acquired a new stake in shares of Danaher during the second quarter valued at $7,895,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR stock opened at $216.41 on Friday. The firm has a market capitalization of $152.13 billion, a price-to-earnings ratio of 38.44, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The company has a 50 day moving average price of $199.46 and a 200 day moving average price of $192.52. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80.

Danaher (NYSE:DHR) last issued its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period last year, the company posted $0.77 EPS. Sell-side analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the stock. Guggenheim cut their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating for the company in a research note on Wednesday, July 22nd. HSBC decreased their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Stifel Nicolaus lowered their price target on shares of Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. TD Cowen cut their price objective on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Finally, DZ Bank initiated coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price on the stock. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.